The money will help accelerate the commercial release of NeoMedical’s Advise system, according to a Feb. 17 news release. Advise complements Neo Medical’s current implants and instruments.
“Looking forward, we will focus on the commercial deployment of the digital component of our platform with Advise, which for the first time brings surgeons real-time, augmented-reality AR visibility for patient-specific spinal treatment,” Neo Medical CEO Vincent Lefauconnier said in the news release.
Funding was led by Swisscom Ventures.
